Sepia Investments and PACs sell 7.49% stake in Corona Remedies via open market
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sepia Investments, Anchor Partners, and Sage Investment Trust acting in concert and classified as non-promoters sold a combined 45,80,891 shares (7.49%) of Corona Remedies on the NSE open market on June 17, 2026. Sepia sold 43,28,943 shares (7.08%), Anchor sold 1,61,861 (0.26%), and Sage sold 90,087 (0.15%). Combined holding fell to 13.41% from 20.91% before the sale.
Large open-market sale by non-promoter investor group may weigh on the stock and signals reduced conviction from a major holder.